AHA 2019

Akshay Desai is a cardiologist at Brigham and Womens Hospital, Cardiology.

Dr. Binita Shah was awarded her MD and MS in Clinical Investigation from NYU School of Medicine, and completed her Interventional Cardiology fellowship at NYU in 2011. Dr. Shah is Associate Director of Research for Interventional Cardiology at NYU. She is also Associate Director of Interventional Cardiology at the VA New York Harbor Healthcare System. Dr. Shah conducts clinical translational research and utilizes a multi-disciplinary approach to the treatment of CAD with a focus on optimization of the underlying inflammatory and glucometabolic milieu. She was a KL2 Scholar, recipient of the AHA Clinical Research grant, and PI of the NIH-funded Colchicine-PCI trial and ColCorona-US study. Dr. Shah is currently PI of the NIH-funded CLEAR SYNERGY Biospecimen Substudy. Dr. Shah serves on national committees through SCAI, AHA, and ACC, is Associate Editor for Circulation Cardiovascular Intervention, and serves on the SCAI Board of Trustees

A professor of medicine at Duke NUS Medical School. Singapore. Features in 3 videos on Wondr Medical. Carolyn Lam generally speaks on Chronic Heart Failure, Renal Failure and Cardiovascular Disease, Diabetes and the Heart, Sodium-Glucose Co-Transporter 2 (SGLT2), and Stable Coronary Artery Disease (CAD).

David Mazer is a professor of anaesthesia at University of Toronto, Toronto, Canada.

Works at Cordoba National University, Cordoba, Argentina. Features in 3 videos on Wondr Medical. Felipe Martínez generally speaks on Heart Failure, Chronic Heart Failure, Renal Failure and Cardiovascular Disease, Cardiology, and Diabetes.

Harriett Van Spall is a cardiology at McMaster University, Hamilton, Ontario, Canada.

James Hamilton is a vp clinical development at Arrowhead Pharmaceuticals, Pasadena, CA, US.

A professor of medicine at Stony Brook University Hospital, New York, USA. Features in 1 video on Wondr Medical. Javed Butler generally speaks on Heart Failure with Preserved Ejection Fraction (HFPEF).

Jean-Claude Tardif is a professor of medicine at Montreal Heart Institute, Montreal, Canada.

A professor of cardiology at University of Glasgow, Glasgow, UK. Features in 1 video on Wondr Medical. John McMurray generally speaks on Heart Failure with Preserved Ejection Fraction (HFPEF).

Joost Daemen is an interventional cardiology at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.

Jorrit Lemkes is an interventional cardiologist at Amsterdam UMC, VU Amsterdam, The Netherlands.

Kausik Ray is a professor of public health at Imperial College, London, UK.

A professor of cardiology at Keele University, Keele, United Kingdom. Features in 3 videos on Wondr Medical. Mamas Mamas generally speaks on Cardiovascular Pharmacotherapy, Covid-19, Covid19 Managing Covid, Drug coated balloons (DCB), and Primary Percutaneous Coronary Intervention (PPCI).

Marc P. Bonaca is a cardiologist at University of Colorado School of Medicine, Aurora, Colorado, US.

Matthew Budoff is a professor of medicine at Harbor-UCLA Medical Center, Torrance, California, USA.

Mikhail Kosiborod is a professor of medicine at University of Missouri, Kansas City School of Medicine, Missouri, USA.

Milton Packer is an interventional cardiologist at Baylor University Medical Center, Dallas, Texas, US.

Dr. Pinilla-Echeverri is originally from Colombia and received her MD from Universidad de Caldas in Manizales, Caldas, Colombia. She moved to Spain to complete training in Internal Medicine and Cardiology and then moved to Canada to complete an Interventional Cardiology, non-invasive Cardiac Computed Tomography Angiography imaging and advanced Intracoronary Imaging fellowship at McMaster University, Hamilton, Canada. She also obtained a Master’s Degree in Health Research Methodology from Universidad de Cordoba; and PhD Degree from Universidad Complutense in Madrid, Spain. She actively participates in Acute Coronary Syndrome research at the Population Health Research Institute. Dr. Pinilla-Echeverri is an Associate Professor at the Department of Medicine Division of Cardiology at McMaster University and currently an Interventional Cardiology Staff at Hamilton Health Sciences and Niagara Health. She is the Program Director of the Intravascular Coronary Imaging Fellowship in McMaster University and has trained international interventional cardiologists in Imaging. She is passionate about acute coronary syndrome research and leads educational programs worldwide.

Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.

Nihar Desai is an assistant professor of medicine at Yale School of Medicine, New Haven, CT, USA.

Prof. Dr. Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions (among others transcatheter heart interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair). He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure.

Pierre Amarenco is a cardiologist at Paris University, Paris, France.

R Scott Wright is a cardiologist at Mayo Clinic, Rochester, MN, USA.

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.

Sanket Dhurva is an assistant professor of medicine at University of California, San Francisco, San Francisco, CA, US.

Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.